2nd Quarter - Report

CENCORA, INC. for CENCORA, INC.

Firm
Client
Income
—
Expenses
$226,700
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

H.R. 1392 and S. 1221, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price.

LobbyistCovered position, as disclosed
RITA E NORTON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1392 (111th), S. 1221 (111th)

Pharmacy PHA

H.R. 1392 and S. 1221, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price.

LobbyistCovered position, as disclosed
RITA E NORTON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1392 (111th), S. 1221 (111th)

Taxation/Internal Revenue Code TAX

Potential repeal of LIFO ("Last In First Out") Tax as healthcare reform offset.

LobbyistCovered position, as disclosed
RITA E NORTON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.